Compendium of Cancer Genome Aberrations

GTS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
Removed Hieu Nguyen, since only Parisa Kargaran is working on these pages in Chapter 6.
 
(68 intermediate revisions by 5 users not shown)
Line 7: Line 7:
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.


<br />
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
Line 19: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS)
|
|
----<br />
====CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS)====
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Neurofibromatosis Type 1 (NF1)]]
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|7/12/2023
|
|PENDING
|
|Madina Sukhanova (Madina S)
|
|Named based on GTS5 book
|-
|[[Familial Adenomatous Polyposis (APC)]]
|Disease
|Jennifer Laffin
|8/20/2023
|
|PENDING
|
|MS / LS
|
|Named based on GTS5 book
|-
|[[Peutz-Jeghers Syndrome (STK11)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM)
|
|
----<br />
----<br />
Line 103: Line 40:
----<br />
----<br />
|-
|-
|CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS)
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Li-Fraumeni Syndrome (TP53)]]
|Disease
|Disease
|
|Farid Ullah, MS PhD
|
|2/19/2025
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)]]||Disease||Jennie Thurston
|7/2/2023
|
|
|PENDING
|PENDING
|
|
|LS
|Eric McGinnis
|
|
|Named based on GTS5 book
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5.
|-
|-
|[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)|''BRCA''-Related Cancer Predisposition Syndrome (''BRCA1'', ''BRCA2'')]]
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
|Disease
|Disease
|Constance Albarracin / Katherine Geiersbach
|Amrit Kaler, MD
|
|7/15/2024
|
|
|PENDING
|PENDING
|
|
|Katherine Geiersbach
|Eric McGinnis
|
|
|Named based on GTS5 book (page created 12/30/23)
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAN5, ENDO5.
|-
|-
|[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
|Disease
|Constance Albarracin / Katherine Geiersbach / Jun Liao
|
|
|PENDING
|
|Katherine Geiersbach
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[Ataxia-Telangiectasia Syndrome (ATM)]]
|Disease
|Evin Gulbahce / Katherine Geiersbach
|
|
|PENDING
|
|Katherine Geiersbach
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 6 (TELOMERE MAINTENANCE)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|CHAPTER 8 (RNA REGULATION)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[DICER1-Related Tumour Predisposition Syndrome (DICER1)]]
|Disease
|Disease
|Jennie Thurston
|Kristina Garcia, GC
|7/2/2023
|9/10/2025
|
|
|PENDING
|PENDING
|
|
|LS
|Eric McGinnis
|
|Named based on GTS5 book
|-
|CHAPTER 9 (PROTEIN REGULATION)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|}
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[GTS5:Hereditary_papillary_renal_carcinoma_(MET)|Hereditary papillary renal carcinoma (MET)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[GTS5:Juvenile_polyposis_syndrome_(BMPR1A,_SMAD4)|Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
|Disease
|
|
|
|
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO DIG5.
|-
|-
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]]
Line 352: Line 82:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]]
Line 363: Line 93:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]]
Line 374: Line 104:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5.
|-
|-
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]]
Line 385: Line 115:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5, STBT5.
|-
|-
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]]
Line 396: Line 126:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5.
|-
|-
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
|Disease
|Disease
|Ngoni Faya (trainee);
Madina Sukhanova
|7/12/2023
|
|
|PENDING
|
|
|Madina Sukhanova (Madina S)
|
|
|
|'''Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. However prior content and so kept original page content and added new template to the top for authors to modify, Also, content in online WHO EYE5, HAN5, ENDO5, PEDS5, CNS5, SBTB5, BRST5.'''
|
|-
|
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
Line 418: Line 160:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO PEDS5, CNS5.
|-
|-
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]]
Line 429: Line 171:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]]
Line 440: Line 182:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
Line 451: Line 193:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]]
Line 462: Line 204:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO FEMA5, THOR5, MALE5, CNS5, ENDO5, SKIN5.
|-
|-
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]]
Line 473: Line 215:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
|Disease
|Disease
|Jennifer Laffin
|8/20/2023
|
|
|PENDING
|
|
|MS / LS
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAN5, PEDS5, CNS5, DIG5.
|
 
|
(had given author a recent version of the GTS template from 9-1-24 to originally use but no content added into the page).
|
|
|-
|-
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
Line 495: Line 239:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO DIG5.
|-
|-
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
|[[GTS5:AXIN2-associated_polyposis_(AXIN2)|AXIN2-associated polyposis (AXIN2)]]
|Disease
|Disease
|Suhasini Lulla (trainee working with Eric as mentor)
|9/23/25
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|
|
|
|-
|-
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
|[[GTS5:Serrated_polyposis_(RNF43)|Serrated polyposis (RNF43)]]
Line 517: Line 261:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO DIG5.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
|[[GTS5:WT1_related_tumour_predisposition_syndrome_(WT1)|WT1 related tumour predisposition syndrome (WT1)]]
|Disease
|Disease
|Kristina Garcia, GC
|9/10/2025
|
|
|PENDING
|
|
|
|Eric McGinnis
|
|
|
|
|
|
|
Line 532: Line 287:
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
|[[GTS5:WAGR_syndrome_(WT1)|WAGR syndrome (WT1)]]
|Disease
|Disease
|Kathleen Bone
|7/12/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO PEDS5.
|
|
|
|
|-
|-
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]]
|Disease
|Disease
|Amrit Kaler, MD
|7/15/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5.
|
|
|
|
|-
|-
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]]
|Disease
|Disease
|Amrit Kaler, MD
|7/15/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, FEMA5, BRST5, DIG5.
|
|
|
|
|-
|-
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
|Disease
|Disease
|Jasmine Baker, PhD
|08/25/2025
|12/31/2025
|
|
|
|
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO BRST5.
|
|
|
|-
|-
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
Line 583: Line 338:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
|[[GTS5:Naevoid_basal_cell_carcinoma_syndrome_-_Gorlin_syndrome_(PTCH1,_SUFU,_GPR161)|Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
|Disease
|Disease
|Ying-Hsia Chu, MD
|6/24/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5, SKIN5, PEDS5, HAN5.
|
|
|
|
|-
|-
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]]
Line 605: Line 360:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
|[[GTS5:ELP1-related_medulloblastoma_predisposition_syndrome(ELP1)|ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
Line 616: Line 371:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5.
|-
|-
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]]
Line 627: Line 382:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
|[[GTS5:Brooke-Spiegler_syndrome_(CYLD)|Brooke-Spiegler syndrome (CYLD)]]
Line 638: Line 404:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, HAN5.
|-
|-
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]]
|Disease
|Disease
|Faisel Ibrahim
|1/20/2026
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5.
|
|
|
|
|-
|-
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]
|Disease
|Disease
|Amrit Kaler, MD
|7/15/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAN5, CNS5, FEMA5, BRST5.
|
|
|
|
|-
|-
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_&#948;_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase &#948; Syndrome - APDS (PIK3CD)]]
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_&#948;_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase &#948; Syndrome - APDS (PIK3CD)]]
Line 671: Line 437:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
|[[GTS5:Multiple_endocrine_neoplasia_type_5,_MAX_related_tumours_(MAX)|Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
Line 682: Line 448:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5.
|-
|-
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]]
Line 693: Line 459:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5.
|-
|-
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]]
Line 704: Line 470:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5.
|-
|-
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]]
Line 715: Line 481:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
|[[GTS5:Hyperparathyroidism_jaw_tumour_syndrome_(CDC73)|Hyperparathyroidism jaw tumour syndrome (CDC73)]]
|Disease
|Disease
|Ying-Hsia Chu, MD
|6/24/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
|-
----<br />
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|[[GTS5:Von_Hippel-Lindau_syndrome_(VHL)|Von Hippel-Lindau syndrome (VHL)]]
|Disease
|Lakshmi Chandramohan
|6/24/24
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24.  Had previously added an older template on 6/24/24. Also, content in online WHO EYE5, HAN5, ENDO5, MALE5, PEDS5, CNS5, FEMA5.
|-
|-
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
|[[GTS5:SDH-deficient_tumour_syndrome_-_Hereditary_phaeochromocytoma-paraganglioma_syndromes_(SDHA,_SDHB,_SDHC,_SDHD,_SDHAF2)|SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
|Disease
|Disease
|Amrit Kaler, MD
|7/15/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Had previously added an old template on 7/15/24. Also, content in online WHO ENDO5.
|-
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
|Disease
|Ying-Hsia Chu, MD
|6/24/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO FEMA5, MALE5.
|
|-
|-
|[[GTS5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome_(FH)|Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
|Disease
|Disease
|
|
Line 759: Line 568:
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|
|
|-
====CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS)====
|[[GTS5:Hereditary_tyrosinaemia_type_1_(FAH)|Hereditary tyrosinaemia type 1 (FAH)]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|-
|-
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
|[[GTS5:Li-Fraumeni_syndrome_(TP53)|Li-Fraumeni syndrome (TP53)]]
|Disease
|Disease
|Lakshmi Chandramohan
|6/24/24
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Previously had added an old template on 12/30/23. Also, content in online WHO BRST5, HAN5, PEDS5, CNS5, THOR5, FEMA5, STBT5.
|
|
|
|
|-
|-
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
|Disease
|Disease
|Suhasini Lulla (trainee working with Eric as mentor)
|9/23/25
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, PEDS5, CNS5.
|
|
|
|
|-
|-
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
|[[GTS5:Multiple_endocrine_neoplasia_type_4_(CDKN1B)|Multiple endocrine neoplasia type 4 (CDKN1B)]]
Line 803: Line 622:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5.
|-
|-
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
|Disease
|Disease
|Suhasini Lulla (trainee working with Eric as mentor)
|9/23/25
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
|Disease
|Xiaolin Hu
|12/9/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|-
|-
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]]
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
|Disease
|Disease
|
|
Line 825: Line 666:
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAEM5.
|-
|
|
|-
====CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY)====
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|-
|-
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
|[[GTS5:Lynch_Syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
|Disease
|Disease
|Amrit Kaler, MD
|7/15/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Older GTS-specific template (9-1-24) to page created on 7/15/24. Also, content in online WHO MALE5, FEMA5, PEDS5, DIG5.
|
|
|
|
|-
|-
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
|[[GTS5:Muir-Torre_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
Line 858: Line 709:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, SKIN5.
|-
|-
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
|Disease
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
|
|
|LS
|
|
|
|'''Named based on GTS5 book (page created 12/30/23). Also, content in online WHO PEDS5, CNS5.'''
|
 
|
'''<br />'''
|
'''GTS-SPECIFIC TEMPLATE (9-1-24).  NEEDS TO BE MODIFIED TO NEWEST TEMPLATE VERSION GTS-Specific Template (11-7-24)!!!!'''
|
|-
|-
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
|Disease
|Disease
|Parisa Kargaran
|1/9/26
|1/16/2026
|COMPLETE
|
|
|Katherine Geiersbach
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5, FEMA5.
|
|
|
|
|
|-
|-
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
|Disease
|Disease
|Parisa Kargaran, Hieu Nguyen
|9/23/2025
|1/16/2026
|COMPLETE
|
|
|Katherine Geiersbach
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5.
|
|
|
|
|
|-
|-
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
|Disease
|Disease
|Xiaolin Hu
|12/9/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|
|
|
|-
|-
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
|[[GTS5:Fanconi_anaemia_(FANC_genes)|Fanconi anaemia (FANC genes)]]
|Disease
|Disease
|Nada Assaf
|6/11/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 6/11/24. Also, content in online WHO HAEM5, HAN5, CNS5.
|
|-
|
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
|[[GTS5:MUTYH-associated_polyposis_(MUTYH)|MUTYH-associated polyposis (MUTYH)]]
Line 924: Line 789:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
|[[GTS5:NTHL1-related_tumour_syndrome_(NTHL1)|NTHL1-related tumour syndrome (NTHL1)]]
Line 935: Line 800:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
|[[GTS5:MBD4-associated_neoplasia_syndrome_(MBD4)|MBD4-associated neoplasia syndrome (MBD4)]]
Line 946: Line 811:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]]
Line 957: Line 822:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, PEDS5.
|-
|-
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
|Disease
|Disease
|Emilie Lalonde
|12/16/2025
|
|
|PENDING
|
|
|Katherine Geiersbach (Eric McGinnis as needed)
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO HAEM5, HAN5, FEM5, BRST5.
|
|
|
|
|-
|-
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
Line 979: Line 844:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5.
|-
|-
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
|Disease
|Disease
|Scott Smith
|2/7/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|
|
|
|-
|-
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
|[[GTS5:Polymerase_proofreading-associated_polyposis_(POLD1,_POLE)|Polymerase proofreading-associated polyposis (POLD1, POLE)]]
|Disease
|Disease
|Scott Smith
|2/7/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|
|
|
|-
|-
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
|[[GTS5:Bloom_syndrome_(BLM)|Bloom syndrome (BLM)]]
|Disease
|Disease
|Nada Assaf
|6/11/2024
|
|
|PENDING
|
|
|Xiaolin (Lynn) Hu
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 6/11/24. Also, content in online WHO HAEM5, HAN5.
|
|
|
|
|-
|-
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
|[[GTS5:Werner_syndrome_(WRN)|Werner syndrome (WRN)]]
|Disease
|Disease
|Scott Smith
|2/7/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO STBT5.
|
|-
|
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
|[[GTS5:Rothmund-Thomson_syndrome_(ANAPC1,_RECQL4)|Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
Line 1,034: Line 910:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO STBT5, PEDS5.
|-
|-
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
|[[GTS5:DDX41-related_haematologic_tumour_predisposition_syndrome_(DDX41)|DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
Line 1,045: Line 921:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
|[[GTS5:Mosaic_variegated_aneuploidy_(BUB1B,_CEP57,_TRIP13,_BUB1,_BUB3)|Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
Line 1,056: Line 932:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
|[[GTS5:Klinefelter_syndrome|Klinefelter syndrome]]
|Disease
|Disease
|Kathleen Bone
|7/12/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. No other books have content.
|
|
|
|
|-
|-
|[[GTS5:Turner_syndrome|Turner syndrome]]
|[[GTS5:Turner_syndrome|Turner syndrome]]
|Disease
|Disease
|Kathleen Bone
|7/12/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|'''Named based on GTS5 book (page created 7/12/24). No other books have content.'''
'''<br />'''
'''GTS-SPECIFIC TEMPLATE (9-1-24).  NEEDS TO BE MODIFIED TO NEWEST TEMPLATE VERSION GTS-Specific Template (11-7-24)!!!!'''
|-
|[[GTS5:Down_syndrome|Down syndrome]]
|Disease
|Kathleen Bone
|7/12/2024
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. No other books have content.
|-
|
|
====CHAPTER 6 (TELOMERE MAINTENANCE)====
|
|
|-
----<br />
|[[GTS5:Down_syndrome|Down syndrome]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
|Disease
|Disease
|Parisa Kargaran
|1/21/2026
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, HAN5.
|-
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
|Disease
|Parisa Kargaran
|1/21/2026
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING)====
|
|
|-
----<br />
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
|[[GTS5:Beckwith-Wiedemann_spectrum_(IGF2;_CDKN1C)|Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
Line 1,122: Line 1,054:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO PEDS5.
|-
|-
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
|[[GTS5:Enchondromatosis_(IDH1,_IDH2)|Enchondromatosis (IDH1, IDH2)]]
Line 1,133: Line 1,065:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO STBT5, PEDS5.
|-
|-
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
|[[GTS5:Rhabdoid_tumour_predisposition_syndrome_(SMARCB1,_SMARCA4)|Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
Line 1,144: Line 1,076:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5, PEDS5.
|-
|-
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
|[[GTS5:Schwannomatosis_(SMARCB1,_LZTR1)|Schwannomatosis (SMARCB1, LZTR1)]]
Line 1,155: Line 1,087:
|
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5.
|-
|-
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
|[[GTS5:Clear_cell_meningioma_predisposition_syndrome_(SMARCE1)|Clear cell meningioma predisposition syndrome (SMARCE1)]]
Line 1,166: Line 1,098:
|
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|-
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
|[[GTS5:Weaver_syndrome_(EZH2)|Weaver syndrome (EZH2)]]
Line 1,177: Line 1,109:
|
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|-
|
|
|-
====CHAPTER 8 (RNA REGULATION)====
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
|
|Disease
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
|Disease
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
|
|
|LS
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO ENDO5, PEDS5, CNS5, FEMA5.
|-
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
|Disease
|Kristina Garcia, GC
|9/10/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
|
|-
|-
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
|[[GTS5:Goldenhar_syndrome_(MYT1,_SF3B2)|Goldenhar syndrome (MYT1, SF3B2)]]
Line 1,210: Line 1,163:
|
|
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5.
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
====CHAPTER 9 (PROTEIN REGULATION)====
|
----<br />
|
----<br />
|
----<br />
|
|
|-
----<br />
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
|Disease
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|[[GTS5:BAP1-related_tumour_predisposition_syndrome_(BAP1)|BAP1-related tumour predisposition syndrome (BAP1)]]
|Disease
|Ying-Hsia Chu, MD
|6/24/2025
|
|
|PENDING
|
|
|Eric McGinnis
|
|
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO THOR5, MALE5, CNS5, EYE5, SKIN5, PEDS5.
|-
|-
|}<br />
|}<br />
Retrieved from "https://test.ccga.io/index.php/GTS5:Volunteer_Assignments_and_Opportunities"